Other studies have shown that high adropin levels improve insulin sensitivity and carbohydrate and lipid metabolism while suppressing hepatic steatosis [23], suggesting that restoring proper adropin levels can be a valuable therapeutic approach for the treatment of NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.